You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Epilepsy

Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome

  • Technology appraisal guidance
  • Reference number: TA615
  • Published:  18 December 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Draft guidance
  4. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality impact assessment (Scoping) (PDF 161 KB)

    Published:
    18 December 2019

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 328 KB)

    Published:
    11 November 2019
  • Committee papers (PDF 2.48 MB)

    Published:
    11 November 2019

Draft guidance

  • Draft guidance

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 354 KB)

    Published:
    23 August 2019
  • Committee papers (PDF 6.3 MB)

    Published:
    23 August 2019
  • Public committee slides (PDF 1.21 MB)

    Published:
    23 August 2019

Invitation to participate

  • Final scope (PDF 249 KB)

    Published:
    31 October 2018
  • Final matrix (PDF 218 KB)

    Published:
    31 October 2018
  • NICE's response to comments on the draft scope and provisional matrix (PDF 260 KB)

    Published:
    31 October 2018
  • Equality impact assessment (Scoping) (PDF 177 KB)

    Published:
    31 October 2018
Back to top